Form 4: Ocugen Director Kirsten Castillo Acquires 25,000 Shares in Open Market Purchase

Ocugen director Kirsten Castillo purchased 25,000 shares of common stock at a weighted average price of $0.9139 per share.

Summary

• Kirsten Castillo, a director at Ocugen, Inc., acquired 25,000 shares of the company's common stock on November 22, 2024.
• The shares were purchased at a weighted average price of $0.9139 per share.
• The transactions occurred in multiple purchases with prices ranging from $0.9138 to $0.9139.
• Following the transaction, Ms. Castillo directly owns 75,000 shares of Ocugen stock.

Sentiment

Score: 6

Explanation: The document reflects a routine insider transaction. While the purchase is a positive signal, it's not a major event that would drastically alter sentiment.

Positives

• A director's purchase of shares can be seen as a positive signal of confidence in the company's future prospects.

Industry Context

This is a standard SEC Form 4 filing, which is common for corporate insiders who trade their company's stock. It provides transparency into the trading activities of company directors.

Comparison to Industry Standards

• Form 4 filings are a standard practice for publicly traded companies in the US, ensuring transparency of insider trading.
• The purchase by a director is a common occurrence and is not unusual in the context of corporate governance.

Stakeholder Impact

• The purchase may have a slightly positive impact on shareholder sentiment, as it indicates confidence from a company director.

Key Dates

Keywords

Ocugen, insider trading, stock purchase, Kirsten Castillo, director, OCGN, common stock